Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05527769
Other study ID # ICO-2021-36
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 7, 2022
Est. completion date November 30, 2023

Study information

Verified date September 2023
Source Institut Cancerologie de l'Ouest
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective, single-center, non-randomized study of immediate breast reconstruction (IBR) using a pre- or retro-pectoral technique in patients with breast cancer who have undergone total mastectomy. The technique used is chosen according to the characteristics of the breast, the morphology of the patient and her wishes after informed information on the different techniques. The aim is not to compare the two techniques but rather to evaluate the early functional results of these two methods in order to better understand them and to propose a management adapted to each. The main objective will be to evaluate the postoperative pain by BPI questionnaire. The investigators also wish to observe the functional results of the homolateral upper limb by DASH questionnaire, the quality of life by BREAST Q questionnaire and the occurrence of complications.


Description:

describe the occurrence of complications between pre-pectoral and retro-pectoral technique in patients with breast cancer who have total mastectomy. evaluate the postoperative pain by Brief Pain Inventory (BPI) self assesment observe the functional results of the homolateral upper limb by Disabilities of the Arm, Shoulder and Hand (DASH) self assesment observe quality of life by BREAST Q questionary


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date November 30, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Major patients 2. With breast cancer and indication for total mastectomy 3. With a desire for immediate breast reconstruction 4. Total mastectomy procedure and Immediate Breast Reconstruction by Pre-pectoral or Retro-Pectoral prosthesis 5. Information of the patient and collection of his/her non-opposition 6. Affiliation with a social security´ scheme, or beneficiary of such a scheme Exclusion Criteria: 1. Prophylactic mastectomies 2. Metastatic patients 3. Patients requiring another surgical technique 4. Person in an emergency situation, person of legal age under legal protection (adult under guardianship, curators or safeguard of justice), or unable to express consent, 5. Impossibility to submit to the medical follow-up of the trial for geographical, social or psychological reasons 6. Pregnant or likely to be pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
mastectomy + immediate breast reconstruction
pre- or retro pectoral prosthesis

Locations

Country Name City State
France Institut de Cancerologie de L'Ouest Saint-Herblain

Sponsors (1)

Lead Sponsor Collaborator
Institut Cancerologie de l'Ouest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Describe postoperative pain and functional results Brief Pain Inventory (BPI) short form - 4 scales from 1 (No pain) to 10 (max pain) + 7 scales from 1 (no discomfort) to 10 (max discomfort) to determine if the pain interfered with activities of daily living 6 month
Secondary Assessing quality of life and aesthetic satisfaction breast questionary pre-post operative reconstruction module 6 months
Secondary Evaluate the function of the homolateral upper limb Disabilities of the Arm, Shoulder and Hand self-assessment 6 months
Secondary Describe the occurrence of postoperative complications postoperative complications 3 months
Secondary Describe the length of operative stay (for the initial reconstruction), for all patients and according to the methods of reconstruction performed duration of hospitalization 3 months
Secondary Describe the duration of drainage for all patients and according to the methods of reconstruction performed duration of drainage in the breast and back, number of punctures and total volume of seroma punctures (classification <2) 3 months
Secondary Describe the number of surgery(s) required to obtain a good aesthetic result number of surgery(s) 3 months
Secondary Describe the number of consultations for seroma punctures, for all patients and according to the methods of reconstruction performed number of punctures and total volume of seroma punctures (classification <2) 3 months
See also
  Status Clinical Trial Phase
Completed NCT03080623 - Ultrasound-based Diagnostic Model for Differentiating Malignant Breast Lesion From Benign Lesion
Completed NCT06376578 - Exercise Interventions for Improving Health in Breast Cancer Survivors N/A
Completed NCT03004534 - A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide Early Phase 1
Recruiting NCT05020574 - Microbiome and Association With Implant Infections Phase 2
Active, not recruiting NCT06277141 - The Vitality Mammography Messaging Study N/A
Completed NCT03555227 - USG PECS vs LIA for Breast Cancer Surgery N/A
Completed NCT03270111 - High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women N/A
Active, not recruiting NCT03917082 - Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer Phase 2
Recruiting NCT05561842 - Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
Completed NCT04554056 - Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF Phase 2/Phase 3
Not yet recruiting NCT06351332 - A Phase I/II Single-arm Trial of Azenosertib (ZN-c3) Combined With Carboplatin and Pembrolizumab in Patients With Metastatic Triple-negative Breast Cancer (ZAP-IT) Phase 1/Phase 2
Active, not recruiting NCT03127995 - Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence N/A
Active, not recruiting NCT02237469 - Prone Breast Radiotherapy Treatment Planning Observational Study
Completed NCT01204125 - Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients Phase 2
Recruiting NCT04565054 - Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC Phase 3
Recruiting NCT03956641 - Evolution of the Physical Condition in Treated Cancer Patients N/A
Recruiting NCT06087120 - Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting NCT06058936 - Exercises Using Virtual Reality on Cancer Patients N/A
Completed NCT03470935 - Non-interventional Study Evaluating Gynecological Impact of Diagnosis and Treatment of Breast Cancer in Patients Younger
Recruiting NCT06025604 - ACTIVPROSEIN : Professional Activity After Breast Cancer